Sanjiv Agarwala, MD

Professor of Medicine
School of Medicine
Temple University
Philadelphia, PA
Chief, Oncology and Hematology
St. Luke’s Cancer Center
Easton, PA

Dr. Agarwala is the Chief of Medical Oncology and Hematology at St. Luke’s Cancer Center and Professor of Medicine at Temple University School of Medicine in Philadelphia, Pennsylvania. He is nationally and internationally recognized as an expert in the research and treatment of melanoma and immunotherapy of cancer and has presented and led numerous conferences and meetings across the globe.

Dr. Agarwala received his undergraduate education and Medical Degree from Bombay University. He completed his medical training through residencies and fellowships at the University of Bombay in India, Otago University in New Zealand, and the University of Pittsburgh in Pennsylvania.

Dr. Agarwala has written and contributed to over 150 publications and book chapters on melanoma and other research areas. He is Board Certified in Oncology, Hematology, and Internal Medicine, as well as an active member of several professional and scientific societies, such as the American Association for Cancer Research, the American Society of Clinical Oncology, the European Society of Medical Oncology, and the Society for Melanoma Research.

Dr. Agarwala has been the principal investigator for multiple clinical trials involving immunotherapy and targeted therapy for melanoma and other malignancies, as he has special interest and expertise in immunotherapy for cancer. As a result of his dedication to melanoma and immunotherapy research, Dr. Agarwala has received several honors, including listings as one of America’s top doctors for cancer and best doctors in the United States.

Dr. Agarwala has no relevant financial relationships to disclose in relation to the content of this activity.

Back to top